Symptom relief and cytokine modulation by clarithromycin in mild COVID-19 pneumonia: an exploratory, multicenter, randomized-controlled open-label trial (CAME-COVID study).

Findings indicate that 400 mg may be insufficient for suppressing serum cytokines; however, 800 mg of CAM reportedly suppressed serum TNF-α, G-CSF, and IL-15 and disease severity 42 – 44 and showed a trend of decreased oxygen use.

also in 53,322 other papers